Detection of micrometastatic cells in breast cancer by RT-PCR for the mammaglobin gene

Cancer Detection and Prevention

Volumn 26, Issue 1, 2002, Pages 60-63

  Bossolasco, Patrizia ^a   Ricci, Clara ^a   Farina, Gabriella ^c   Soligo, Davide ^b   Pedretti, Donata ^c   Scanni, Alberto ^c   Deliliers, Giorgio Lambertenghi ^b  

^a Fondazione Matarelli   (Italy)

^b Ctro T di M IRCCS O M   (Italy)

^c FATEBENEFRATELLI HOSPITAL   (Italy)

Author keywords

Breast neoplasm; Mammaglobin; Neoplasm circulating cells; RT PCR

Indexed keywords

ADENOCARCINOMA; BLOOD CELLS; BONE MARROW; BONE MARROW NEOPLASMS; BREAST NEOPLASMS; CASE-CONTROL STUDIES; DNA PRIMERS; DNA, NEOPLASM; FEMALE; HUMANS; LYMPHATIC METASTASIS; NEOPLASM CIRCULATING CELLS; NEOPLASM METASTASIS; NEOPLASM PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK FACTORS; RNA, MESSENGER; RNA, NEOPLASM; TUMOR MARKERS, BIOLOGICAL; UTEROGLOBIN;

EID: 0036952136     PISSN: 0361090X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0361-090X(02)00009-0     Document Type: Article

References (16)

1. Cote RJ, Rosen P, Lesser M, et al. Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow disseminated tumor cells. J Clin Oncol 1991;9(10): 1749-56.
2. Frost P, Levin B. Clinical implications of metastatic process. Lancet 1992;339:1458-61.
3. Smith B, Selby P, Southgate J, et al. Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction. Lancet 1991;338:1227-9.
4. Bostick PJ, Chatterjee S, Chi DD, et al. Limitations of specific reverse transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients. J Clin Oncol 1998;16(8):2632-40.
5. Watson MA, Fleming TP. Isolation of differentially expressed sequence tags from human breast cancer. Cancer Res 1994;54:4598-602.
6. Watson MA, Fleming TP. Mammaglobin, a mammary-specific member of the uteroglobin gene family, is over-expressed in human breast cancer. Cancer Res 1996;56(4):860-5.
7. Zach O, Kasparu H, Hehenwarter W, et al. Detection of circulating mammary carcinoma cells in the PB of breast cancer patients via a nested reverse transcriptase polymerase chain reaction assay for mammaglobin mRNA. J Clin Oncol 1999;17(7):2015-9.
8. Watson MA, Dintzis S, Darrow CM, et al. Mammaglobin expression in primary, metastatic, and occult breast cancer. Cancer Res 1999;59:3028-31.
9. Grunewald K, Haun M, Urbanek M, et al. Mammaglobin gene expression: a superior marker of breast cancer cells in peripheral blood in comparison to epidermal-growth-factor receptor and cytokeratin-19 . Lab Invest 2000;80(7):1071-7.
10. Diel IJ, Kaufamnn M, Goerner R, et al. Detection of tumor cells in bone marrow of patients with primary breast cancer: a prognostic factor for distant metastasis. J Clin Oncol 1992;10(10):1534-9.
11. Rill DR, Santana VM, Roberts WM, et al. Direct demonstration that autologous bone marrow transplantation for solid tumors can return a multiplicity of tumorigenic cells. Blood 1994;84(2):380-3.
12. Datta YH, Adams P, Droboski W, et al. Sensitive detection of occult breast cancer by the reverse transcriptase polymerase reaction. J Clin Oncol 1994;12:475-82.
13. Schoenfeld A, Kruger K, Gomm J, et al. The detection of micrometastases in the peripheral blood and bone marrow of patients with breast cancer using immunohistochemistry and reverse transcriptase polymerase chain reaction for keratin 19. Eur J Cancer 1997:33:854-61.
14. Mori M, Mimori K, Ueo H, et al. Clinical significance of molecular detection of carcinoma cells in lymph nodes and peripheral blood by reverse transcription-polymerase chain reaction in patients with gastrointestinal or breast carcinoma. J Clin Oncol 1998;16(1):128-32.
15. Zippelius A, Kufer P, Honold MW, et al. Limitations of reverse transcriptase polymerase chain reaction analyses for detection of micrometastatic epithelial cancer cells in bone marrow. J Clin Oncol 1997;15:2701-8.
16. Glaves D, Huben R, Weiss L. Haematogenous dissemination of cells from human renal adenocarcinoma. Br J Cancer 1998;54:32-5.